Product NDC: | 0093-7206 |
Proprietary Name: | Mirtazapine |
Non Proprietary Name: | Mirtazapine |
Active Ingredient(s): | 15 mg/1 & nbsp; Mirtazapine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-7206 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076119 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030129 |
Package NDC: | 0093-7206-93 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0093-7206-93) > 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-7206-19) |
NDC Code | 0093-7206-93 |
Proprietary Name | Mirtazapine |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0093-7206-93) > 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-7206-19) |
Product NDC | 0093-7206 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mirtazapine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20030129 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | MIRTAZAPINE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes |